Denis Burger

Denis R.
Burger was the founder of Epitope, Inc., founded in 1981, where the title of Chairman was held from 1981 to 1990.
Dr. Burger was the founder of Trinity Biotech Plc, founded in 1992, with the title of Non-Executive Director held from 2009 to 2010.
Current jobs include Executive Chairman at Biocide, Inc. since 2009; Chairman at AMES Technology, Inc.; Lead Independent Director at Aptose Biosciences, Inc. since 2007; President at Yamhill Valley Vineyards, Inc. since 1983; Partner at Sovereign Ventures LLC; and Managing Member at Paradigm Ventures LLC since 1990.
Former jobs include Chairman & Chief Executive Officer at Sarepta Therapeutics, Inc. from 1996 to 2007; Chairman & Chief Executive Officer at AVI Biopharma, Inc.; Vice Chairman & Chief Science Officer at CytoDyn, Inc. from 2016 to 2018; Executive Chairman at BioCurex, Inc.; Director at Paulson Capital (Delaware) Corp.
from 2013 to 2014 and from 2007 to 2009; and Professor-Microbiology & Immunology at Oregon Health & Science University from 1969 to 1985.
Education includes undergraduate degree from the University of California, Berkeley in 1965, and graduate and doctorate degrees from the University of Arizona in 1969.